Results 61 to 70 of about 914 (71)

[Clinical characteristics and prognostic analysis of carbapenem-resistant Enterobacteriaceae bloodstream infections in patients with hematologic diseases]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhang LN, Cui YQ, Lin QS, Xu CH, Sun JL, Cao YG, Cao WB, Liang C, Chen X, Zhai WH, Ma QL, Zhang RL, Wei JL, Yang DL, Pang AM, He Y, Jiang EL, Han MZ, Feng SZ.   +18 more
europepmc   +1 more source

[Targeting chimera technology: A new tool for undruggable in breast cancer]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Chen Z, Shen S, Song X, Xiao B.
europepmc   +1 more source

[Efficacy and long-term follow-up report of FCR regimen in the first-line treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Lu X, Xia Y, Miao Y, Qiu TL, Dai LMJ, Zhou ZY, Jin H, Qiu HR, Qiao C, Wu YJ, Fan L, Xu W, Li JY, Zhu HY.   +13 more
europepmc   +1 more source

[Shihu Mixture alleviates diabetic cardiomyopathy in rats by Sirt3-mediated upregulation of myocardial mitochondrial mitophagy pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Lin X, He Y, Shi H, Liu J, Hu H.
europepmc   +1 more source

[Preparation of chiral metal organic framework modified silica monolithic capillary column and its application in enantioseparations of chiral drugs]. [PDF]

Se Pu
Song RK, Liao G, Lin JL, Wu JL, Huang L.
europepmc   +1 more source

[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Xia K, Gao T.
europepmc   +1 more source

[Immune Checkpoints Mediate Tumor Immune Regulation 
through Metabolic Pathways]. [PDF]

Zhongguo Fei Ai Za Zhi
Du W, Tang X, Zhou Y, Li M, Jin Z, Dou J, Zhao J.   +6 more
europepmc   +1 more source

In vitro study of a siRNA delivery liposome constructed with an ionizable cationic lipid. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Hu D, Zou J, Nie S, Wang Y, Wang S.
europepmc   +1 more source

[Chinese expert consensus on prevention and treatment of immunotherapeutic and molecular targeted agents-related infections in patients with hematological malignancies (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Infectiology Group, Chinese Society of Hematology, Chinese Medical Association, Lymphocytic Disease Group, Chinese Society of Hematology, Chinese Medical Association, Lymphoma Expert Committee of Chinese Society of Clinical Oncology.   +6 more
europepmc   +1 more source